GH Research to meet investors at MS conference
GH Research PLC (GHRS) reports that it will hold one-on-one investor meetings during the Morgan Stanley 24th Annual Global Healthcare Conference, scheduled for September 14–16, 2026, in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
GH Research PLC (GHRS) reports that it will hold one-on-one investor meetings during the Morgan Stanley 24th Annual Global Healthcare Conference, scheduled for September 14–16, 2026, in New York. The company discloses this as a report of a foreign private issuer on Form 6-K.
Key Figures
Conference dates: September 14–16, 2026
Form type: Form 6-K
Signature date: September 11, 2026
3 metrics
Conference dates
September 14–16, 2026
Schedule for the Morgan Stanley 24th Annual Global Healthcare Conference where GH Research PLC will hold investor meetings
Form type
Form 6-K
Report of foreign private issuer under the Securities Exchange Act of 1934
Signature date
September 11, 2026
Date the report was signed by the Company Secretary
Key Terms
foreign private issuer, Form 6-K, Form 20-F, Form 40-F, +2 more
6 terms
foreign private issuer regulatory
"Report of foreign private issuer pursuant to Rule 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Form 6-K regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
Form 20-F regulatory
"whether the registrant files or will file annual reports under cover of Form 20-F"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
Form 40-F regulatory
"whether the registrant files or will file annual reports under cover of Form 40-F"
A Form 40-F is a standardized annual filing used by certain Canadian companies that trade in U.S. markets to give U.S. regulators and investors the same core financial statements and key disclosures they file in Canada. Think of it as a translated, formally packaged annual report that lets investors in a different marketplace compare a company’s results, governance and risks more easily, which reduces uncertainty and helps investment decisions.
one-on-one investor meetings financial
"will hold one-on-one investor meetings during the Morgan Stanley"
One-on-one investor meetings are private conversations between company representatives and individual investors, where they discuss the company's performance, plans, and outlook. These meetings help investors gain a clearer understanding of the company’s future prospects, much like a personal consultation, enabling them to make more informed decisions about their investments. They are an important way for investors to build trust and gather detailed insights directly from company leaders.
Annual Global Healthcare Conference financial
"Morgan Stanley 24th Annual Global Healthcare Conference"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did GHRS (GH Research PLC) announce in this Form 6-K?
GH Research PLC announced that it will hold one-on-one investor meetings during the Morgan Stanley 24th Annual Global Healthcare Conference in New York, providing investors with an opportunity to engage directly with the company’s management.
When will GHRS attend the Morgan Stanley 24th Annual Global Healthcare Conference?
GH Research PLC stated it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference, which is scheduled for September 14–16, 2026, in New York, and will hold one-on-one investor meetings during the event.
What type of meetings will GHRS hold at the conference?
GH Research PLC disclosed that it will hold one-on-one investor meetings during the Morgan Stanley 24th Annual Global Healthcare Conference, allowing individual institutional or other investors to meet directly with company representatives.
Where will GH Research PLC’s investor meetings take place in September 2026?
GH Research PLC stated that its one-on-one investor meetings will occur in New York during the Morgan Stanley 24th Annual Global Healthcare Conference, scheduled for September 14–16, 2026.
What form did GHRS use to report these investor meetings?
GH Research PLC reported these planned one-on-one investor meetings on a Form 6-K as a report of a foreign private issuer under the Securities Exchange Act of 1934.
AI-generated analysis. How Rhea-AI works. Not financial advice.
